Founder of Biostar. Expert in combinatorial biosynthesis and synthetic biology. More than 30 years of research experience in the development of natural microbial small-molecule drugs and has made breakthroughs of key technologies in biosynthesis and fermentation productions. Participated in or led the successful development of multiple novel anticancer drugs. Dr. Tang has published more than 40 research papers in the world’s leading academic journals such as Lancet Oncology, Science, JACS, PNAS, and Chemistry & Biology, and is the inventor of more than 40 patents granted by China, USA and other countries.

Bachelor's degree in microbiology from Wuhan University, master's degree in molecular biology from Peking Union Medical College, and doctorate degree in pharmacy and biochemistry from the University of Wisconsin at Madison, USA, followed by postdoctoral research at the University of Wisconsin. Dr. Tang has served as a senior scientist at a life science company in the US and the professor of molecular medicine at Dalian University of Technology.

Co-founder of Biostar. Specialized in molecular oncology, long engaged in the research of mechanisms underlying cell transformation and has made important contributions to the understanding of oncogenic signaling. Participated in or led the successful development of a number of novel anticancer drugs and demonstrated impressive research and development achievements. Dr. Qiu has published more than 40 research papers in prestigious scientific journals such as Nature, Cell, PNAS, Current Biology, Molecular and Cellular Biology, Chemistry and Biology, and Lancet Oncology, and is the inventor of multiple patents.

Bachelor's degree in virology and a master's degree in viral biochemistry from Wuhan University. Doctorate degree in molecular and cell biology from Utrecht University. Research scholar at the University of California, San Francisco, and a post-doctoral research fellow at the University of California, Berkeley. Has served as scientists in charge of drug discovery, target identification, cell-based assays, and preclinical studies in several biopharmaceutical companies and the professor of molecular medicine at Dalian University of Technology. 

Over 10 years of experience in portfolio management, business development and alliance management of innovative oncology products. Simon is currently responsible for operation related work at Biostar including project management, business development, public relations, et al.

Bachelor's degree in English Pharmacy and doctorate degree in Pharmaceutics from Shenyang Pharmaceutical University. Simon has led multiple oncology projects' overall lifecycle management and in-licensing. 2018 "Innovative and Entrepreneurial Talent" of Jiangsu Province. Simon has worked for Austarpharma (US), China Resources Saike Pharmaceuticals and EOC Pharma as project leader, Sr. R&D manager, Sr. Director of project management and business development.

More than 20 years of experience in production, site operation and management, as well as quality control. In charge of manufacturing and quality control at Biostar since 2015.

Master's degree in Pharmaceutical Engineering from Sichuan University. Before joining Biostar, he served as manager of quality assurance, manager of production technology, executive deputy general manager of other biopharmaceutical companies. He has been responsible multiple times for facility establishing, production quality system construction and GMP certification. 

More than 10 years of rich experience in capital operation areas such as investment and financing, IPO, acquisition and merger. Since July 2020, Kevin has been serving as the board secretary and director of investment and financing at Biostar.

Master's degree of Finance from Nankai University. Has worked for the investment banking divisions of UBS Securities, Morgan Stanley Huaxin Securities, China Securities, and Guosen Securities as senior manager, vice president or director at different institutions. He is good at communication and coordination, team management, as well as creative problem-solving.

Chinese Certified Public Accountant; senior certified public accountant; Certified Tax Agent. Rich financial working experience in biopharmaceutical industry.

Bachelor's degree in accounting from Southwestern University of Finance and Economics.  Mr. Peng has worked for Factory Construction Engineering Bureau of the Ministry of Railways, Chengdu Ruixin Pharmaceuticals, Sinco Pharmaceuticals, et al as financing director and board director.